 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Cellular Component	GO:0005739	mitochondrion	1	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	1	1.680979e-1	1.000000e+0	1.000000e+0	5.687579e+0	1.758217e-1	1	1586	5.000000e-1	6.305170e-4	unnamed	NDUFAF2
GO Cellular Component	GO:0016021	integral to membrane	2	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	2	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	SMIM15
GO Cellular Component	GO:0031224	intrinsic to membrane	3	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	3	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	SMIM15
GO Cellular Component	GO:0044444	cytoplasmic part	4	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	5	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	NDUFAF2
GO Cellular Component	GO:0044425	membrane part	5	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	4	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	SMIM15
GO Cellular Component	GO:0016020	membrane	6	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	6	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	SMIM15
GO Cellular Component	GO:0005737	cytoplasm	7	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	7	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	NDUFAF2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	8	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	8	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0043227	membrane-bounded organelle	9	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	9	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0043229	intracellular organelle	10	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	10	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0043226	organelle	11	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	11	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0044424	intracellular part	12	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	12	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0005622	intracellular	13	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	13	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0044464	cell part	14	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	14	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	NDUFAF2
GO Cellular Component	GO:0005623	cell	15	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	15	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	NDUFAF2
Human Phenotype	HP:0001404	Hepatocellular necrosis	1	1.018291e-3	1.000000e+0	1.000000e+0	9.820376e+2	1.018291e-3	1	1.018291e-3	1.000000e+0	1	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	NDUFAF2
Human Phenotype	HP:0006965	Acute necrotizing encephalopathy	2	1.160040e-3	1.000000e+0	1.000000e+0	8.620394e+2	1.160040e-3	1	1.160040e-3	1.000000e+0	2	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	NDUFAF2
Human Phenotype	HP:0008316	Abnormal mitochondria in muscle tissue	3	1.228751e-3	1.000000e+0	1.000000e+0	8.138345e+2	1.228751e-3	1	1.228751e-3	1.000000e+0	3	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	NDUFAF2
Human Phenotype	HP:0004481	Progressive macrocephaly	4	1.249626e-3	1.000000e+0	1.000000e+0	8.002395e+2	1.249626e-3	1	1.249626e-3	1.000000e+0	4	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002605	Hepatic necrosis	5	1.272189e-3	1.000000e+0	1.000000e+0	7.860467e+2	1.272189e-3	1	1.272189e-3	1.000000e+0	4	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	NDUFAF2
Human Phenotype	HP:0006846	Acute encephalopathy	6	1.652567e-3	1.000000e+0	1.000000e+0	6.051193e+2	1.652567e-3	1	1.652567e-3	1.000000e+0	6	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	NDUFAF2
Human Phenotype	HP:0001427	Mitochondrial inheritance	7	1.850358e-3	1.000000e+0	1.000000e+0	5.404361e+2	1.850358e-3	1	1.850358e-3	1.000000e+0	11	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	NDUFAF2
Human Phenotype	HP:0000712	Emotional lability	8	2.295203e-3	1.000000e+0	1.000000e+0	4.356913e+2	2.295203e-3	1	2.295203e-3	1.000000e+0	10	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	NDUFAF2
Human Phenotype	HP:0007305	CNS demyelination	9	2.311133e-3	1.000000e+0	1.000000e+0	4.326882e+2	2.311133e-3	1	2.311133e-3	1.000000e+0	9	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002490	Increased CSF lactate	10	2.366912e-3	1.000000e+0	1.000000e+0	4.224914e+2	2.366912e-3	1	2.366912e-3	1.000000e+0	12	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002415	Leukodystrophy	11	2.491087e-3	1.000000e+0	1.000000e+0	4.014312e+2	2.491087e-3	1	2.491087e-3	1.000000e+0	8	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002181	Cerebral edema	12	2.719255e-3	1.000000e+0	1.000000e+0	3.677478e+2	2.719255e-3	1	2.719255e-3	1.000000e+0	7	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	NDUFAF2
Human Phenotype	HP:0003546	Exercise intolerance	13	2.800749e-3	1.000000e+0	1.000000e+0	3.570473e+2	2.800749e-3	1	2.800749e-3	1.000000e+0	13	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NDUFAF2
Human Phenotype	HP:0000543	Optic disc pallor	14	3.211519e-3	1.000000e+0	1.000000e+0	3.113792e+2	3.211519e-3	1	3.211519e-3	1.000000e+0	13	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NDUFAF2
Human Phenotype	HP:0003287	Abnormality of mitochondrial metabolism	15	3.967787e-3	1.000000e+0	1.000000e+0	2.520296e+2	3.967787e-3	1	3.967787e-3	1.000000e+0	17	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002151	Increased serum lactate	16	3.995195e-3	1.000000e+0	1.000000e+0	2.503007e+2	3.995195e-3	1	3.995195e-3	1.000000e+0	22	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	NDUFAF2
Human Phenotype	HP:0012103	Abnormality of the mitochondrion	17	4.073392e-3	1.000000e+0	1.000000e+0	2.454956e+2	4.073392e-3	1	4.073392e-3	1.000000e+0	18	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	NDUFAF2
Human Phenotype	HP:0000602	Ophthalmoplegia	18	4.301437e-3	1.000000e+0	1.000000e+0	2.324805e+2	4.301437e-3	1	4.301437e-3	1.000000e+0	13	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002921	Abnormality of the cerebrospinal fluid	19	4.657334e-3	1.000000e+0	1.000000e+0	2.147151e+2	4.657334e-3	1	4.657334e-3	1.000000e+0	23	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	NDUFAF2
Human Phenotype	HP:0002171	Gliosis	20	4.841109e-3	1.000000e+0	1.000000e+0	2.065643e+2	4.841109e-3	1	4.841109e-3	1.000000e+0	13	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NDUFAF2
Human Phenotype	HP:0001259	Coma	21	5.560377e-3	1.000000e+0	1.000000e+0	1.798439e+2	5.560377e-3	1	5.560377e-3	1.000000e+0	19	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	NDUFAF2
Human Phenotype	HP:0100705	Abnormality of the glial cells	22	5.741252e-3	1.000000e+0	1.000000e+0	1.741780e+2	5.741252e-3	1	5.741252e-3	1.000000e+0	24	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	NDUFAF2
Human Phenotype	HP:0000580	Pigmentary retinopathy	23	5.743337e-3	1.000000e+0	1.000000e+0	1.741148e+2	5.743337e-3	1	5.743337e-3	1.000000e+0	21	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NDUFAF2
Human Phenotype	HP:0100852	Abnormal fear/anxiety-related behavior	24	6.402585e-3	1.000000e+0	1.000000e+0	1.561869e+2	6.402585e-3	1	6.402585e-3	1.000000e+0	27	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	NDUFAF2
Human Phenotype	HP:0011400	Abnormal CNS myelination	25	6.500457e-3	1.000000e+0	1.000000e+0	1.538353e+2	6.500457e-3	1	6.500457e-3	1.000000e+0	29	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	NDUFAF2
Human Phenotype	HP:0001423	X-linked dominant inheritance	26	6.528342e-3	1.000000e+0	1.000000e+0	1.531782e+2	6.528342e-3	1	6.528342e-3	1.000000e+0	20	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	NDUFAF2
Human Phenotype	HP:0001298	Encephalopathy	27	6.546159e-3	1.000000e+0	1.000000e+0	1.527613e+2	6.546159e-3	1	6.546159e-3	1.000000e+0	25	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	NDUFAF2
Human Phenotype	HP:0000618	Blindness	28	6.933097e-3	1.000000e+0	1.000000e+0	1.442357e+2	6.933097e-3	1	6.933097e-3	1.000000e+0	28	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	NDUFAF2
Human Phenotype	HP:0001254	Lethargy	29	7.240727e-3	1.000000e+0	1.000000e+0	1.381077e+2	7.240727e-3	1	7.240727e-3	1.000000e+0	26	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	NDUFAF2
Human Phenotype	HP:0003128	Lactic acidosis	30	7.763196e-3	1.000000e+0	1.000000e+0	1.288129e+2	7.763196e-3	1	7.763196e-3	1.000000e+0	30	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001272	Cerebellar atrophy	31	7.839562e-3	1.000000e+0	1.000000e+0	1.275581e+2	7.839562e-3	1	7.839562e-3	1.000000e+0	33	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003487	Babinski sign	32	7.878417e-3	1.000000e+0	1.000000e+0	1.269291e+2	7.878417e-3	1	7.878417e-3	1.000000e+0	32	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002013	Vomiting	33	8.572818e-3	1.000000e+0	1.000000e+0	1.166478e+2	8.572818e-3	1	8.572818e-3	1.000000e+0	31	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001943	Hypoglycemia	34	8.866645e-3	1.000000e+0	1.000000e+0	1.127822e+2	8.866645e-3	1	8.866645e-3	1.000000e+0	33	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	NDUFAF2
Human Phenotype	HP:0004302	Functional motor problems.	35	9.225985e-3	1.000000e+0	1.000000e+0	1.083895e+2	9.225985e-3	1	9.225985e-3	1.000000e+0	37	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001399	Hepatic failure	36	9.279254e-3	1.000000e+0	1.000000e+0	1.077673e+2	9.279254e-3	1	9.279254e-3	1.000000e+0	35	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002376	Developmental regression	37	9.522267e-3	1.000000e+0	1.000000e+0	1.050170e+2	9.522267e-3	1	9.522267e-3	1.000000e+0	36	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001410	Decreased liver function	38	1.036810e-2	1.000000e+0	1.000000e+0	9.644966e+1	1.036810e-2	1	1.036810e-2	1.000000e+0	42	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NDUFAF2
Human Phenotype	HP:0012447	Abnormal myelination	39	1.038592e-2	1.000000e+0	1.000000e+0	9.628419e+1	1.038592e-2	1	1.038592e-2	1.000000e+0	46	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003676	Progressive disorder	40	1.041484e-2	1.000000e+0	1.000000e+0	9.601683e+1	1.041484e-2	1	1.041484e-2	1.000000e+0	41	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001332	Dystonia	41	1.072440e-2	1.000000e+0	1.000000e+0	9.324529e+1	1.072440e-2	1	1.072440e-2	1.000000e+0	40	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011015	Abnormality of blood glucose concentration	42	1.074606e-2	1.000000e+0	1.000000e+0	9.305738e+1	1.074606e-2	1	1.074606e-2	1.000000e+0	37	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011017	Abnormality of cell physiology	43	1.169780e-2	1.000000e+0	1.000000e+0	8.548614e+1	1.169780e-2	1	1.169780e-2	1.000000e+0	39	1.347939e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000597	Ophthalmoparesis	44	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	49	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	NDUFAF2
Human Phenotype	HP:0004372	Reduced consciousness/confusion	45	1.224302e-2	1.000000e+0	1.000000e+0	8.167919e+1	1.224302e-2	1	1.224302e-2	1.000000e+0	43	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001265	Hyporeflexia	46	1.363560e-2	1.000000e+0	1.000000e+0	7.333742e+1	1.363560e-2	1	1.363560e-2	1.000000e+0	45	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001425	Heterogeneous	47	1.490701e-2	1.000000e+0	1.000000e+0	6.708254e+1	1.490701e-2	1	1.490701e-2	1.000000e+0	47	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001639	Hypertrophic cardiomyopathy	48	1.549127e-2	1.000000e+0	1.000000e+0	6.455250e+1	1.549127e-2	1	1.549127e-2	1.000000e+0	52	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001941	Acidosis	49	1.550843e-2	1.000000e+0	1.000000e+0	6.448106e+1	1.550843e-2	1	1.550843e-2	1.000000e+0	53	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002017	Nausea and vomiting	50	1.584584e-2	1.000000e+0	1.000000e+0	6.310803e+1	1.584584e-2	1	1.584584e-2	1.000000e+0	50	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000998	Hypertrichosis	51	1.653657e-2	1.000000e+0	1.000000e+0	6.047204e+1	1.653657e-2	1	1.653657e-2	1.000000e+0	43	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001260	Dysarthria	52	1.657413e-2	1.000000e+0	1.000000e+0	6.033498e+1	1.657413e-2	1	1.657413e-2	1.000000e+0	51	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	NDUFAF2
Human Phenotype	HP:0004360	Abnormality of acid-base homeostasis	53	1.679508e-2	1.000000e+0	1.000000e+0	5.954125e+1	1.679508e-2	1	1.679508e-2	1.000000e+0	57	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002793	Abnormal pattern of respiration	54	1.743451e-2	1.000000e+0	1.000000e+0	5.735750e+1	1.743451e-2	1	1.743451e-2	1.000000e+0	47	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000969	Edema	55	1.939212e-2	1.000000e+0	1.000000e+0	5.156733e+1	1.939212e-2	1	1.939212e-2	1.000000e+0	55	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001638	Cardiomyopathy	56	2.024024e-2	1.000000e+0	1.000000e+0	4.940652e+1	2.024024e-2	1	2.024024e-2	1.000000e+0	62	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001637	Abnormality of the myocardium	57	2.048425e-2	1.000000e+0	1.000000e+0	4.881799e+1	2.048425e-2	1	2.048425e-2	1.000000e+0	64	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001257	Spasticity	58	2.102269e-2	1.000000e+0	1.000000e+0	4.756765e+1	2.102269e-2	1	2.102269e-2	1.000000e+0	67	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003679	Pace of progression	59	2.214217e-2	1.000000e+0	1.000000e+0	4.516270e+1	2.214217e-2	1	2.214217e-2	1.000000e+0	61	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001417	X-linked inheritance	60	2.233691e-2	1.000000e+0	1.000000e+0	4.476894e+1	2.233691e-2	1	2.233691e-2	1.000000e+0	54	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000256	Macrocephaly	61	2.332999e-2	1.000000e+0	1.000000e+0	4.286328e+1	2.332999e-2	1	2.332999e-2	1.000000e+0	58	2.369323e-2	1.000000e+0	1.000000e+0	4.195581e+1	2.383460e-2	1	215	5.000000e-1	4.651163e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001315	Reduced tendon reflexes	62	2.367878e-2	1.000000e+0	1.000000e+0	4.223191e+1	2.367878e-2	1	2.367878e-2	1.000000e+0	59	2.577339e-2	1.000000e+0	1.000000e+0	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011032	Abnormality of fluid regulation	63	2.390611e-2	1.000000e+0	1.000000e+0	4.183031e+1	2.390611e-2	1	2.390611e-2	1.000000e+0	63	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	NDUFAF2
Human Phenotype	HP:0010985	Gonosomal inheritance	64	2.405674e-2	1.000000e+0	1.000000e+0	4.156839e+1	2.405674e-2	1	2.405674e-2	1.000000e+0	56	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	NDUFAF2
Human Phenotype	HP:0008872	Feeding difficulties in infancy	65	2.531351e-2	1.000000e+0	1.000000e+0	3.950459e+1	2.531351e-2	1	2.531351e-2	1.000000e+0	60	2.621103e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	66	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	72	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003593	Infantile onset	67	2.620028e-2	1.000000e+0	1.000000e+0	3.816753e+1	2.620028e-2	1	2.620028e-2	1.000000e+0	66	2.806993e-2	1.000000e+0	1.000000e+0	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001251	Ataxia	68	2.648195e-2	1.000000e+0	1.000000e+0	3.776157e+1	2.648195e-2	1	2.648195e-2	1.000000e+0	70	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003202	Amyotrophy	69	2.705294e-2	1.000000e+0	1.000000e+0	3.696455e+1	2.705294e-2	1	2.705294e-2	1.000000e+0	69	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001347	Hyperreflexia	70	2.789222e-2	1.000000e+0	1.000000e+0	3.585229e+1	2.789222e-2	1	2.789222e-2	1.000000e+0	76	3.428974e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	312	5.000000e-1	3.205128e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002093	Respiratory insufficiency	71	2.790110e-2	1.000000e+0	1.000000e+0	3.584089e+1	2.790110e-2	1	2.790110e-2	1.000000e+0	77	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001508	Failure to thrive	72	2.902184e-2	1.000000e+0	1.000000e+0	3.445681e+1	2.902184e-2	1	2.902184e-2	1.000000e+0	74	3.341799e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	304	5.000000e-1	3.289474e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	73	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	79	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	NDUFAF2
Human Phenotype	HP:0100851	Abnormal emotion/affect behavior	74	2.918196e-2	1.000000e+0	1.000000e+0	3.426774e+1	2.918196e-2	1	2.918196e-2	1.000000e+0	65	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000648	Optic atrophy	75	2.952567e-2	1.000000e+0	1.000000e+0	3.386883e+1	2.952567e-2	1	2.952567e-2	1.000000e+0	75	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000508	Ptosis	76	2.965278e-2	1.000000e+0	1.000000e+0	3.372365e+1	2.965278e-2	1	2.965278e-2	1.000000e+0	68	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003812	Phenotypic variability	77	3.032972e-2	1.000000e+0	1.000000e+0	3.297096e+1	3.032972e-2	1	3.032972e-2	1.000000e+0	72	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011968	Feeding difficulties	78	3.142552e-2	1.000000e+0	1.000000e+0	3.182127e+1	3.142552e-2	1	3.142552e-2	1.000000e+0	70	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000587	Abnormality of the optic nerve	79	3.320424e-2	1.000000e+0	1.000000e+0	3.011663e+1	3.320424e-2	1	3.320424e-2	1.000000e+0	80	3.896867e-2	1.000000e+0	1.000000e+0	2.540986e+1	3.935480e-2	1	355	5.000000e-1	2.816901e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011362	Abnormal hair quantity	80	3.605802e-2	1.000000e+0	1.000000e+0	2.773308e+1	3.605802e-2	1	3.605802e-2	1.000000e+0	78	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001276	Hypertonia	81	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	82	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001324	Muscle weakness	82	3.916358e-2	1.000000e+0	1.000000e+0	2.553393e+1	3.916358e-2	1	3.916358e-2	1.000000e+0	86	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002795	Functional respiratory abnormality	83	4.088885e-2	1.000000e+0	1.000000e+0	2.445654e+1	4.088885e-2	1	4.088885e-2	1.000000e+0	85	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011443	Abnormality of coordination	84	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	84	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000479	Abnormality of the retina	85	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	88	4.829244e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	441	5.000000e-1	2.267574e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000486	Strabismus	86	4.438473e-2	1.000000e+0	1.000000e+0	2.253027e+1	4.438473e-2	1	4.438473e-2	1.000000e+0	81	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002167	Neurological speech impairment	87	4.456011e-2	1.000000e+0	1.000000e+0	2.244160e+1	4.456011e-2	1	4.456011e-2	1.000000e+0	83	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001392	Abnormality of the liver	88	4.545608e-2	1.000000e+0	1.000000e+0	2.199926e+1	4.545608e-2	1	4.545608e-2	1.000000e+0	99	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000505	Visual impairment	89	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	89	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	NDUFAF2
Human Phenotype	HP:0004325	Decreased body weight	90	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	89	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000407	Sensorineural hearing impairment	91	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	87	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001317	Abnormality of the cerebellum	92	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	96	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000759	Abnormality of the peripheral nervous system	93	4.946470e-2	1.000000e+0	1.000000e+0	2.021644e+1	4.946470e-2	1	4.946470e-2	1.000000e+0	93	5.196604e-2	1.000000e+0	1.000000e+0	1.899053e+1	5.265783e-2	1	475	5.000000e-1	2.105263e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000504	Abnormality of vision	94	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	95	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	95	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	91	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000359	Abnormality of the inner ear	96	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	92	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000639	Nystagmus	97	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	94	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011007	Age of onset	98	5.358267e-2	1.000000e+0	1.000000e+0	1.866275e+1	5.358267e-2	1	5.358267e-2	1.000000e+0	103	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003674	Onset	99	5.502040e-2	1.000000e+0	1.000000e+0	1.817508e+1	5.502040e-2	1	5.502040e-2	1.000000e+0	108	6.530370e-2	1.000000e+0	1.000000e+0	1.505927e+1	6.640430e-2	1	599	5.000000e-1	1.669449e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001595	Abnormality of the hair	100	5.637295e-2	1.000000e+0	1.000000e+0	1.773901e+1	5.637295e-2	1	5.637295e-2	1.000000e+0	97	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011458	Abdominal symptom	101	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	98	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001263	Global developmental delay	102	5.775253e-2	1.000000e+0	1.000000e+0	1.731526e+1	5.775253e-2	1	5.775253e-2	1.000000e+0	104	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000496	Abnormality of eye movement	103	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	100	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	NDUFAF2
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	104	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	105	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002088	Abnormality of the lung	105	5.867133e-2	1.000000e+0	1.000000e+0	1.704410e+1	5.867133e-2	1	5.867133e-2	1.000000e+0	117	6.990679e-2	1.000000e+0	1.000000e+0	1.405062e+1	7.117122e-2	1	642	5.000000e-1	1.557632e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	106	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	106	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001098	Abnormality of the fundus	107	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	106	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	NDUFAF2
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	108	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	109	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	109	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	100	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011805	Abnormality of muscle morphology	110	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	115	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000240	Abnormality of skull size	111	6.394702e-2	1.000000e+0	1.000000e+0	1.563795e+1	6.394702e-2	1	6.394702e-2	1.000000e+0	102	6.305155e-2	1.000000e+0	1.000000e+0	1.560640e+1	6.407627e-2	1	578	5.000000e-1	1.730104e-3	unnamed	NDUFAF2
Human Phenotype	HP:0004323	Abnormality of body weight	112	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	109	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001252	Muscular hypotonia	113	6.484906e-2	1.000000e+0	1.000000e+0	1.542042e+1	6.484906e-2	1	6.484906e-2	1.000000e+0	112	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	NDUFAF2
Human Phenotype	HP:0003808	Abnormal muscle tone	114	6.512600e-2	1.000000e+0	1.000000e+0	1.535485e+1	6.512600e-2	1	6.512600e-2	1.000000e+0	113	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011138	Abnormality of skin adnexa	115	6.863693e-2	1.000000e+0	1.000000e+0	1.456942e+1	6.863693e-2	1	6.863693e-2	1.000000e+0	114	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	NDUFAF2
Human Phenotype	HP:0100022	Abnormality of movement	116	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	119	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001249	Intellectual disability	117	7.044946e-2	1.000000e+0	1.000000e+0	1.419457e+1	7.044946e-2	1	7.044946e-2	1.000000e+0	111	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	118	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	116	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000365	Hearing impairment	119	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	120	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001627	Abnormality of the heart	120	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	118	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000364	Hearing abnormality	121	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	121	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002060	Abnormality of the cerebrum	122	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	122	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NDUFAF2
Human Phenotype	HP:0100547	Abnormality of the forebrain	123	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	124	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001510	Growth delay	124	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	122	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NDUFAF2
Human Phenotype	HP:0001250	Seizures	125	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	125	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011442	Abnormality of central motor function	126	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	127	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	NDUFAF2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	127	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	126	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000004	Onset and clinical course	128	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	130	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002086	Abnormality of the respiratory system	129	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	128	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	NDUFAF2
Human Phenotype	HP:0012443	Abnormality of the brain	130	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	129	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	NDUFAF2
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	131	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	133	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	NDUFAF2
Human Phenotype	HP:0011804	Abnormality of muscle physiology	132	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	132	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000929	Abnormality of the skull	133	1.006699e-1	1.000000e+0	1.000000e+0	9.933458e+0	1.006699e-1	1	1.006699e-1	1.000000e+0	131	1.002336e-1	1.000000e+0	1.000000e+0	9.720366e+0	1.028768e-1	1	928	5.000000e-1	1.077586e-3	unnamed	NDUFAF2
Human Phenotype	HP:0000598	Abnormality of the ear	134	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	134	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	NDUFAF2
Human Phenotype	HP:0012373	Abnormal eye physiology	135	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	136	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	NDUFAF2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	136	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	135	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	NDUFAF2
Human Phenotype	HP:0012374	Abnormality of the globe	137	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	137	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	NDUFAF2
Human Phenotype	HP:0012372	Abnormal eye morphology	138	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	139	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	NDUFAF2
Human Phenotype	HP:0001507	Growth abnormality	139	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	138	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	NDUFAF2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	140	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	146	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	NDUFAF2
Human Phenotype	HP:0003011	Abnormality of the musculature	141	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	141	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	NDUFAF2
Human Phenotype	HP:0001438	Abnormality of the abdomen	142	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	143	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	NDUFAF2
Human Phenotype	HP:0001574	Abnormality of the integument	143	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	142	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	NDUFAF2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	144	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	144	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	NDUFAF2
Human Phenotype	HP:0009121	Abnormal axial skeleton morphology	145	1.232157e-1	1.000000e+0	1.000000e+0	8.115849e+0	1.232157e-1	1	1.232157e-1	1.000000e+0	140	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	NDUFAF2
Human Phenotype	HP:0100543	Cognitive impairment	146	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	145	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	147	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	153	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000478	Abnormality of the eye	148	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	147	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	NDUFAF2
Human Phenotype	HP:0011446	Abnormality of higher mental function	149	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	148	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000234	Abnormality of the head	150	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	150	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000152	Abnormality of head and neck	151	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	151	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	NDUFAF2
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	152	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	149	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000924	Abnormality of the skeletal system	153	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	152	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	NDUFAF2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	154	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	154	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000707	Abnormality of the nervous system	155	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	155	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000005	Mode of inheritance	156	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	156	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000118	Phenotypic abnormality	157	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	157	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	NDUFAF2
Human Phenotype	HP:0000001	All	158	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	158	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	NDUFAF2
Disease Ontology	DOID:3652	Leigh disease	1	2.754949e-4	6.157311e-1	6.157311e-1	3.629832e+3	2.754949e-4	1	2.754949e-4	1.000000e+0	1	3.325574e-4	7.432658e-1	7.432658e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	NDUFAF2
Disease Ontology	DOID:700	mitochondrial disease	2	6.588467e-3	1.000000e+0	1.000000e+0	1.517804e+2	6.588467e-3	1	6.588467e-3	1.000000e+0	2	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NDUFAF2
Disease Ontology	DOID:655	inborn errors of metabolism	3	2.149170e-2	1.000000e+0	1.000000e+0	4.652958e+1	2.149170e-2	1	2.149170e-2	1.000000e+0	3	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	NDUFAF2
Disease Ontology	DOID:1749	squamous cell carcinoma	4	7.192071e-2	1.000000e+0	1.000000e+0	1.390420e+1	7.192071e-2	1	7.192071e-2	1.000000e+0	4	7.652380e-2	1.000000e+0	1.000000e+0	1.281321e+1	7.804445e-2	1	704	5.000000e-1	1.420455e-3	unnamed	NDUFAF2
Disease Ontology	DOID:2428	epithelioma	5	7.206581e-2	1.000000e+0	1.000000e+0	1.387621e+1	7.206581e-2	1	7.206581e-2	1.000000e+0	5	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	NDUFAF2
Disease Ontology	DOID:3168	squamous cell neoplasm	6	8.073938e-2	1.000000e+0	1.000000e+0	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	6	8.492093e-2	1.000000e+0	1.000000e+0	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	NDUFAF2
Disease Ontology	DOID:0014667	disease of metabolism	7	1.387898e-1	1.000000e+0	1.000000e+0	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	7	1.487750e-1	1.000000e+0	1.000000e+0	6.461676e+0	1.547586e-1	1	1396	5.000000e-1	7.163324e-4	unnamed	NDUFAF2
Disease Ontology	DOID:157	epithelial carcinoma	8	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	9	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	NDUFAF2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	9	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	8	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	NDUFAF2
Disease Ontology	DOID:305	carcinoma	10	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	10	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	NDUFAF2
Disease Ontology	DOID:162	cancer	11	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	11	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	NDUFAF2
Disease Ontology	DOID:4	disease	12	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	12	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	NDUFAF2
MSigDB Pathway	PID_MYC_ACTIVPATHWAY	Validated targets of C-MYC transcriptional activation	1	6.777500e-3	1.000000e+0	1.000000e+0	1.475470e+2	6.777500e-3	1	6.777500e-3	1.000000e+0	1	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	NDUFAF2
MSigDB Perturbation	FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	Cluster 4 of aberrantly hypermethylated genes in blasts from AML (acute myeloid leukemia) patients.	1	8.670688e-3	1.000000e+0	1.000000e+0	1.153311e+2	8.670688e-3	1	8.670688e-3	1.000000e+0	1	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	SMIM15
MSigDB Perturbation	FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	Cluster 7 of aberrantly hypermethylated genes in blasts from AML (acute myeloid leukemia) patients.	2	9.956664e-3	1.000000e+0	1.000000e+0	1.004352e+2	9.956664e-3	1	9.956664e-3	1.000000e+0	2	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	SMIM15
MSigDB Perturbation	FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	Cluster 1 of aberrantly hypermethylated genes in blasts from AML (acute myeloid leukemia) patients.	3	1.107796e-2	1.000000e+0	1.000000e+0	9.026935e+1	1.107796e-2	1	1.107796e-2	1.000000e+0	3	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	SMIM15
MSigDB Perturbation	FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	Cluster 6 of aberrantly hypermethylated genes in blasts from AML (acute myeloid leukemia) patients.	4	1.217646e-2	1.000000e+0	1.000000e+0	8.212565e+1	1.217646e-2	1	1.217646e-2	1.000000e+0	4	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	SMIM15
MSigDB Perturbation	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	Cluster 3 of aberrantly hypermethylated genes in blasts from AML (acute myeloid leukemia) patients.	5	1.416839e-2	1.000000e+0	1.000000e+0	7.057963e+1	1.416839e-2	1	1.416839e-2	1.000000e+0	5	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	SMIM15
MSigDB Perturbation	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	Genes up-regulated in mucinous ovarian carcinoma tumors of low malignant potential (LMP) compared to normal ovarian surface epithelium tissue.	6	1.814520e-2	1.000000e+0	1.000000e+0	5.511099e+1	1.814520e-2	1	1.814520e-2	1.000000e+0	7	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	NDUFAF2
MSigDB Perturbation	KIM_MYC_AMPLIFICATION_TARGETS_UP	Genes positively correlated with amplifications of MYC [GeneID=4609] in SCLC (small cell lung cancer) cell lines.	7	2.171723e-2	1.000000e+0	1.000000e+0	4.604639e+1	2.171723e-2	1	2.171723e-2	1.000000e+0	6	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	NDUFAF2
MSigDB Perturbation	WANG_LMO4_TARGETS_DN	Genes down-regulated in MCF7 cells (breast cancer) engineered to conditionally express LMO4 [GeneID=8543] by a Tet Off system.	8	3.100095e-2	1.000000e+0	1.000000e+0	3.225708e+1	3.100095e-2	1	3.100095e-2	1.000000e+0	8	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	NDUFAF2
MSigDB Perturbation	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	Category B genes: p53-dependent genes whose expression in the absence of S389 phosphorylation is dissimilar to loss of TP53 [GeneID=7157] in MEF (embryonic fibroblast) cells in response to UV-C irradiation.	9	4.740517e-2	1.000000e+0	1.000000e+0	2.109475e+1	4.740517e-2	1	4.740517e-2	1.000000e+0	13	5.778599e-2	1.000000e+0	1.000000e+0	1.705198e+1	5.864420e-2	1	529	5.000000e-1	1.890359e-3	unnamed	SMIM15
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	Genes in the expression cluster 'Early Progenitors Shared': up-regulated in hematopoietic progenitors from adult bone marrow and from fetal liver.	10	4.893719e-2	1.000000e+0	1.000000e+0	2.043436e+1	4.893719e-2	1	4.893719e-2	1.000000e+0	12	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	NDUFAF2
MSigDB Perturbation	ZHANG_BREAST_CANCER_PROGENITORS_UP	Genes up-regulated in cancer stem cells isolated from mammary tumors compared to the non-tumorigenic cells.	11	5.010071e-2	1.000000e+0	1.000000e+0	1.995980e+1	5.010071e-2	1	5.010071e-2	1.000000e+0	9	4.526178e-2	1.000000e+0	1.000000e+0	2.184140e+1	4.578460e-2	1	413	5.000000e-1	2.421308e-3	unnamed	SMIM15
MSigDB Perturbation	PILON_KLF1_TARGETS_UP	Genes up-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	12	5.387062e-2	1.000000e+0	1.000000e+0	1.856299e+1	5.387062e-2	1	5.387062e-2	1.000000e+0	10	5.347664e-2	1.000000e+0	1.000000e+0	1.844683e+1	5.420986e-2	1	489	5.000000e-1	2.044990e-3	unnamed	SMIM15
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	Transcripts enriched in pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	13	5.651646e-2	1.000000e+0	1.000000e+0	1.769396e+1	5.651646e-2	1	5.651646e-2	1.000000e+0	11	5.455490e-2	1.000000e+0	1.000000e+0	1.807715e+1	5.531844e-2	1	499	5.000000e-1	2.004008e-3	unnamed	SMIM15
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	Genes up-regulated in liver tumor compared to the normal adjacent tissue.	14	6.025185e-2	1.000000e+0	1.000000e+0	1.659700e+1	6.025185e-2	1	6.025185e-2	1.000000e+0	14	9.169554e-2	1.000000e+0	1.000000e+0	1.064994e+1	9.389723e-2	1	847	5.000000e-1	1.180638e-3	unnamed	NDUFAF2
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	15	8.753961e-2	1.000000e+0	1.000000e+0	1.142340e+1	8.753961e-2	1	8.753961e-2	1.000000e+0	15	9.317413e-2	1.000000e+0	1.000000e+0	1.047677e+1	9.544925e-2	1	861	5.000000e-1	1.161440e-3	unnamed	SMIM15
MSigDB Predicted Promoter Motifs	V$MEIS1_01	Motif NNNTGACAGNNN matches MEIS1: Meis1, myeloid ecotropic viral integration site 1 homolog (mouse)	1	3.506399e-2	1.000000e+0	1.000000e+0	2.851928e+1	3.506399e-2	1	3.506399e-2	1.000000e+0	1	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	NDUFAF2
InterPro	IPR027877	Small integral membrane protein 15	1	1.318333e-4	1.000000e+0	1.000000e+0	7.585339e+3	1.318333e-4	1	1.318333e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SMIM15
TreeFam	TF314761	NDUFAF2	1	7.735721e-5	6.286047e-1	6.286047e-1	1.292704e+4	7.735721e-5	1	7.735721e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NDUFAF2
TreeFam	TF328386	SMIM15	2	1.318333e-4	1.000000e+0	5.356387e-1	7.585339e+3	1.318333e-4	1	1.318333e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SMIM15
HGNC Gene Families	MITOAF	MITOAF	1	1.999776e-3	9.558929e-1	9.558929e-1	5.000561e+2	1.999776e-3	1	1.999776e-3	1.000000e+0	1	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	NDUFAF2
Ensembl Genes	15228	NDUFAF2	1	7.735721e-5	1.000000e+0	1.000000e+0	1.292704e+4	7.735721e-5	1	7.735721e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NDUFAF2
Ensembl Genes	15230	SMIM15	2	1.318333e-4	1.000000e+0	1.000000e+0	7.585339e+3	1.318333e-4	1	1.318333e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 T cells KRLG1 Int [GeneID=10219] vs those with KRLG1 Hi.	1	1.253498e-2	1.000000e+0	1.000000e+0	7.977674e+1	1.253498e-2	1	1.253498e-2	1.000000e+0	10	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NDUFAF2
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 1 day after stimulation with YF17D vaccine.	2	1.390313e-2	1.000000e+0	1.000000e+0	7.192626e+1	1.390313e-2	1	1.390313e-2	1.000000e+0	3	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_MONO_MAC_UP	Genes up-regulated in comparison of B cells versus monocyte macrophages.	3	1.431782e-2	1.000000e+0	1.000000e+0	6.984302e+1	1.431782e-2	1	1.431782e-2	1.000000e+0	10	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.	4	1.461935e-2	1.000000e+0	1.000000e+0	6.840248e+1	1.461935e-2	1	1.461935e-2	1.000000e+0	5	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	5	1.509093e-2	1.000000e+0	1.000000e+0	6.626495e+1	1.509093e-2	1	1.509093e-2	1.000000e+0	15	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of erythroblasts versus neutrophils.	6	1.562896e-2	1.000000e+0	1.000000e+0	6.398379e+1	1.562896e-2	1	1.562896e-2	1.000000e+0	15	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_MONO_MAC_UP	Genes up-regulated in comparison of NK cells versus monocyte macrophages.	7	1.665736e-2	1.000000e+0	1.000000e+0	6.003353e+1	1.665736e-2	1	1.665736e-2	1.000000e+0	14	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP	Genes up-regulated in comparison of untreated macrophages at 4 h versus those treated with LPS (TLR4 agonist) at 1 h.	8	1.675853e-2	1.000000e+0	1.000000e+0	5.967111e+1	1.675853e-2	1	1.675853e-2	1.000000e+0	4	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE15659_TREG_VS_TCONV_UP	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	9	1.678685e-2	1.000000e+0	1.000000e+0	5.957044e+1	1.678685e-2	1	1.678685e-2	1.000000e+0	2	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN	Genes down-regulated in comparison of erythroblasts versus monocyte macrophages.	10	1.703101e-2	1.000000e+0	1.000000e+0	5.871642e+1	1.703101e-2	1	1.703101e-2	1.000000e+0	8	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.	11	1.705692e-2	1.000000e+0	1.000000e+0	5.862724e+1	1.705692e-2	1	1.705692e-2	1.000000e+0	5	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP	Genes up-regulated in comparison of untreated macrophages from IRAK4 [GeneID=51135] deficient mice  at 4 h versus those treated with LPS (TLR4 agonist) at 4 h.	12	1.754746e-2	1.000000e+0	1.000000e+0	5.698832e+1	1.754746e-2	1	1.754746e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE27786_LSK_VS_NKTCELL_UP	Genes up-regulated in comparison of LSK versus NKT cells.	13	1.839024e-2	1.000000e+0	1.000000e+0	5.437667e+1	1.839024e-2	1	1.839024e-2	1.000000e+0	13	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NDUFAF2
MSigDB Immunologic Signatures	GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN	Genes down-regulated in comparison of wild type macrophage treated with LPS (TLR4 agonist) at 4 h versus those from IRAK4 [GeneID=51135] deficient mice treated with LPS (TLR4 agonist) at 4 h.	14	1.958495e-2	1.000000e+0	1.000000e+0	5.105962e+1	1.958495e-2	1	1.958495e-2	1.000000e+0	15	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of naive CD8 T cells versus memory CD8 T cells.	15	2.042834e-2	1.000000e+0	1.000000e+0	4.895161e+1	2.042834e-2	1	2.042834e-2	1.000000e+0	10	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SMIM15
MSigDB Immunologic Signatures	GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	16	2.066372e-2	1.000000e+0	1.000000e+0	4.839399e+1	2.066372e-2	1	2.066372e-2	1.000000e+0	1	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	NDUFAF2
MSigDB Immunologic Signatures	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	17	2.094484e-2	1.000000e+0	1.000000e+0	4.774447e+1	2.094484e-2	1	2.094484e-2	1.000000e+0	5	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	NDUFAF2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
